Skip to Content

Ecallantide Pregnancy and Breastfeeding Warnings

Ecallantide is also known as: Kalbitor

Medically reviewed by Last updated on Oct 12, 2020.

Ecallantide Pregnancy Warnings

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: C

Animal studies have revealed evidence of developmental toxicity in the presence of mild maternal toxicity. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Ecallantide Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Kalbitor (ecallantide)." Dyax Corporation, Cambridge, MA.

References for breastfeeding information

  1. "Product Information. Kalbitor (ecallantide)." Dyax Corporation, Cambridge, MA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.